Coronavirus Info Center

News & Resources to Support Your Supply Chain

Coronavirus (COVID-19)
Quick Information Center

The coronavirus outbreak is a constantly evolving situation, and The Quick Group is committed to staying in close communication with our customers during this health crisis. This page is designed to provide you with the latest information and answers to your questions regarding how the outbreak is impacting global shipments. We’re also including links to relevant information published by expert sources. If you have questions or need information that is not addressed on this page, please contact your local customer service office or your Quick/Sterling representative.

In the meantime, we remain focused on continuing to deliver the transportation solutions that meet your urgent shipping needs.

Archive News - Feb, 2021

J&J COVID-19 vaccine authorized for use in the United States

28 Feb, 2021 - VACCINE UPDATES - North America
Late Saturday, the FDA granted emergency use authorization to Johnson & Johnson's single-dose coronavirus vaccine. The J&J vaccine is the 3rd to receive the authorization—which will help speed up the vaccine rollout across the United States.

FDA staff endorses Johnson & Johnson single-shot COVID vaccine for emergency use.

If approved, J&J’s application would be the 3rd vaccine authorized for emergency use in the United States—following those developed by Pfizer-BioNTech & Moderna

Pfizer Coronavirus Vaccine Protects Against U.K., South Africa Variants, Study Shows

The vaccine developed by Pfizer appears to be effective against the more transmissible variants of the coronavirus, including the one first discovered in South Africa

The vaccine developed by the University of Oxford & AstraZeneca not only protects people from serious illness & death, it also slows the transmission of the virus.

The researchers' study is the first to demonstrate evidence that any coronavirus vaccine can reduce virus transmission.

Read more:

4 entries total